Some hot wearable technologies stocks
Lexington Biosciences Inc. (LXGTF)
Lexington BioSciences (CSE: LNB) (OTC: LXGTF), introduces HeartSentry, a revolutionary, simple and effective technology for personalized measurement and monitoring of vascular health to detect the potential for cardiovascular disease at its earliest stages. The device is designed to measure the function of the endothelium, the cells that line all arteries and are critical to the prevention of atherosclerosis, heart attacks, and stroke.
Garmin Ltd. (GRMN)
Garmin Ltd., together with its subsidiaries, designs, develops, manufactures, markets, and distributes a range of navigation, communication, and information devices worldwide. It operates through five segments: Auto, Aviation, Marine, Outdoor, and Fitness. The Auto segment offers personal navigation devices; infotainment solutions; and action cameras, as well as mobile applications under the Garmin and NAVIGON names. The Aviation segment provides navigation, communication, flight control, hazard avoidance, weather radar, radar altimeter, datalink weather, in-cockpit and cloud connectivity, automated logbook, voice and touch control, and other products and services; wearables, portables, and apps; and traffic collision avoidance, and terrain awareness and warning systems. It also offers controller-pilot data link, a suite of automatic dependent surveillance-broadcast solutions. The Marine segment provides chartplotters and multi-function displays, fish finders, sounders, autopilot systems, radars, compliant instrument displays, VHF communication radios, handhelds and wrist-worn devices, sailing products, and entertainment products. The Outdoor segment offers outdoor handhelds, wearable devices, golf devices, and dog tracking and training/pet obedience devices. The Fitness segment provides running/multi-sport watches, cycling computers, cycling power meters, cycling safety and awareness products, and activity tracking devices, as well as Garmin Connect and Garmin Connect Mobile, which are Web and mobile platforms for users to track and analyze their fitness and wellness data. The company sells its global positioning system receivers and accessories to retail outlets; and aviation products to aviation dealers and aircraft manufacturers through a network of independent dealers and distributors. Garmin Ltd. was founded in 1990 and is based in Schaffhausen, Switzerland.
An Investment Into Wearables Could Be Healthy For Your Portfolio
Wearable technology has gained much more notoriety as of late with much of its popularity coming from changing lifestyles of young people. This has stoked the demand for not only more connectivity for novelty products but also triggered a cascade of opportunity for traditional industries of scale.
The healthcare segment, for example, has begun to take on a major focus of the wearable tech marketplace and considering the innovations in several new developments in this area within the last two decades, the dawn of medical wearables could already be upon us.
Mobile phones with wearable sensors implanted medical devices, and home-based telehealth devices can help monitor and manage the health of a patient. Much of this has been a result of smartphones making incredible strides in terms of applications. Just think about it, they can now accomplish actual diagnostic tests
The opportunity for big take-overs is also an option in this marketplace. A private company, Withings, was acquired by a big tech company for a cool $191 million. The company introduced a device that actually monitors blood-pressure on the go.
It’s no secret anymore and investors have taken notice of the fact that wearable medical devices are being used for more than just preventative care. Just as an example, it’s also being found useful for athletes who wish to monitor their performance and condition.
In addition, such devices for continuous medical monitoring are being used for outpatients with persistent medical conditions. Doctors who needed to measure and detect behavioral changes for early diagnosis are also available.
For investors, finding early-stage companies has been key to capitalizing on the immense growth that this industry could be set to see. But when you consider that new biometric devices need FDA consideration, the call to action is based on the ability to achieve fast trackability to bring products to market.
Typically speaking, this could mean that the launch of development stage products from certain emerging growth companies isn’t too far off.
We aren’t talking simple “iPhone watches” anymore. Some companies are focusing on developing wearable medical technology that can quantify the function of the endothelium or the cells that line the arteries. So where the competitive advantage lies is in both efficacy